Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,325 | 5 | 58.1% |
| Food and Beverage | $1,270 | 60 | 31.8% |
| Consulting Fee | $405.00 | 1 | 10.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $2,184 | 6 | $0 (2022) |
| Celgene Corporation | $645.64 | 5 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $182.49 | 9 | $0 (2021) |
| GENZYME CORPORATION | $148.78 | 7 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $128.26 | 3 | $0 (2021) |
| Allergan, Inc. | $92.06 | 6 | $0 (2021) |
| ABBVIE INC. | $90.42 | 4 | $0 (2024) |
| UCB, Inc. | $82.00 | 2 | $0 (2021) |
| CSL Behring | $67.82 | 3 | $0 (2021) |
| Neurelis, Inc. | $53.08 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $130.65 | 6 | ABBVIE INC. ($90.42) |
| 2022 | $375.00 | 1 | E.R. Squibb & Sons, L.L.C. ($375.00) |
| 2021 | $3,495 | 59 | E.R. Squibb & Sons, L.L.C. ($1,809) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Podiatry | ||||||
| 08/28/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/07/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: Neuroscience | ||||||
| 11/22/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/17/2021 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Immunology | ||||||
| 11/10/2021 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Immunology | ||||||
| 11/09/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $975.00 | General |
| Category: Neuroscience | ||||||
| 11/01/2021 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Neurology | ||||||
| 11/01/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $4.46 | General |
| Category: Neuroscience | ||||||
| 10/25/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/21/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $34.04 | General |
| Category: Neuroscience | ||||||
| 10/20/2021 | Genentech USA, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Neurology | ||||||
| 10/13/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: PRIMARY CARE | ||||||
| 10/12/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Consulting Fee | Cash or cash equivalent | $405.00 | General |
| Category: Neuroscience | ||||||
| 10/11/2021 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Neurology | ||||||
| 10/05/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: Neuroscience | ||||||
| 10/04/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.67 | General |
| Category: Neuroscience | ||||||
| 09/30/2021 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: NEUROLOGY | ||||||
| 09/27/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $39.20 | General |
| Category: Neurology | ||||||
| 09/09/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.51 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 229 | 246 | $44,480 | $13,512 |
| 2020 | 3 | 221 | 248 | $41,380 | $12,097 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 99 | 112 | $21,840 | $6,624 | 30.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 99 | $13,365 | $3,792 | 28.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 35 | $9,275 | $3,096 | 33.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 116 | 134 | $26,130 | $7,546 | 28.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 92 | 101 | $13,635 | $3,990 | 29.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 13 | $1,615 | $560.15 | 34.7% |
About Shelley Lott, ARNP
Shelley Lott, ARNP is a Acute Care healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1467674721.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shelley Lott, ARNP has received a total of $4,000 in payments from pharmaceutical and medical device companies, with $130.65 received in 2024. These payments were reported across 66 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2,325).
As a Medicare-enrolled provider, Lott has provided services to 450 Medicare beneficiaries, totaling 494 services with total Medicare billing of $25,608. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Knoxville, TN
- Active Since 05/03/2007
- Last Updated 07/08/2007
- Taxonomy Code 363LA2100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467674721
Products in Payments
- ZEPOSIA (Drug) $2,830
- NURTEC ODT (Drug) $182.49
- BOTOX (Biological) $151.83
- AUBAGIO (Drug) $148.78
- Briviact (Drug) $82.00
- Hizentra (Biological) $67.82
- VALTOCO (Drug) $53.08
- Soliris (Drug) $36.12
- RYTARY (Drug) $32.15
- DUOPA (Drug) $30.65
- VUMERITY (Drug) $29.89
- TOSYMRA (Drug) $28.42
- Evrysdi (Drug) $23.08
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $21.85
- Gamunex-C (Biological) $19.96
- JUBLIA (Drug) $18.38
- TROKENDI XR (Drug) $17.38
- Aimovig (Biological) $16.59
- LUMIZYME (Biological) $13.87
- Fycompa (Drug) $13.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Knoxville
Mr. Stephen Miller, Acnp, ACNP
Acute Care — Payments: $86,064
Mr. Timothy Ballard, Acnp, ACNP
Acute Care — Payments: $43,500
Kimberly Smith, Apn, APN
Acute Care — Payments: $13,176
Dr. William Stafford, Agacnp, AGACNP
Acute Care — Payments: $4,313
Mrs. Frankie Cate, Acnp-Bc, ACNP-BC
Acute Care — Payments: $3,165
Kerry Hastey-Witt, Aprn, APRN
Acute Care — Payments: $2,905